NCT02800824View on ClinicalTrials.gov

Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

Budesonide

DRUG

Uceris

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY

NCT02800824 - Bioequivalence Study of Budesonide Rectal Aerosol Foam and Uceris® Rectal Aerosol Foam | Biotech Hunter | Biotech Hunter